Gerber Kawasaki Wealth & Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$973K	Buy
2021 Q4	–	Sell
2021 Q3	$103K	Buy